Symposium Overview

The Miami Brain Symposium will focus on state-of-the-art approaches in the management of primary and metastatic brain tumors, along with an understanding of current standards of care as well as a look at future directions. For one full day this symposium will engage participants, as the expert faculty navigate through complex cases and novel treatment strategies and lively panel discussions.


miami cancer institute logo

Topics this Year

Topics this Year

  • Primary CNS Tumor
  • Immunotherapy Breakthroughs
  • Molecular Profiling of Metastases
  • Systemic Therapy Breakthroughs
  • Tumor Neurosurgical Advances
  • Next Generation Radiation Therapy

Who should attend?

 
  • Adult and Pediatric Neurologists
  • Diagnostic Radiologists
  • Neuro-Oncologists
  • Medical Oncologists
  • Neuroscience Nurses
  • Clinical Pharmacists
  • Nurse Practitioners
  • Radiology Technologists
  • Respiratory Therapists
  • Neuroradiologists
  • Adult and Pediatric Medical Oncologists
  • Neurosurgeons
  • Radiation Oncologists
  • Respiratory Therapists
  • Emergency Medicine Physicians
  • Dietitians
  • Neurosurgery Nurses
  • Physician Assistants
  • Rehabilitation and Pain Management Specialists
  • Other specialists interested in the fields of neuro-oncology and neuroscience

Sponsorship & Exhibit Information

On behalf of the symposium directors and the Baptist Health Continuing Medical Education Department we are pleased to invite you and your company to participate as a sponsor and exhibitor at our upcoming event.


Call for Abstracts

Themes: Brain metastases, targeted therapy, immunotherapy, stereotactic radiosurgery, spine metastases, glioma management, craniopharyngiomas, neurofibromatosis, cognitive preservation in radiation therapy. ​

Upcoming Courses

Visit our Continuing Medical Education Website for upcoming symposiums, as well as our local conferences and online courses, both available at no charge.

Agenda

*Schedules are subject to change.

Friday Dec. 06*

Continental Breakfast, Visit Posters and Exhibits
7:30 a.m.
Welcome and Introduction
(Yazmin Odia, M.D.)
7:55 a.m.

Brain Metastases: One Size Does Not Fit All

[Moderator: Rupesh Kotecha, M.D.​]

Immunotherapy for Melanoma Brain Metastases
(Sarah Weiss, M.D.)

Targeted Therapy for NSCLC Brain Metastases
(Priscilla Brastianos, M.D.)

Stereotactic Radiosurgery and Molecular-Based Therapies
(Rupesh Kotecha, M.D.)

Hippocampal Avoidance Whole-Brain Radiotherapy
(Paul D. Brown, M.D.)

Visit Posters and Exhibits
8:00 a.m.

Improving Outcomes for Spine Metastases

[Moderator: Vitaly Siomin, M.D.]

Stereotactic and Conventional Radiation Strategies
(Mark Bilsky, M.D.)

Improving Outcomes of Spine Surgery
(Vitaly Siomin, M.D.)

Interventional Radiology Advances
(Brian Schiro, M.D.)

Spinal Tumor Imaging
(Kevin Abrams, M.D.)

Case Discussions
(Matthew Hall, M.D.)
10:00 a.m.
Lunch
12:05 p.m.

Advancing Glioma Management

[Moderator: Yazmin Odia, M.D.]

Chemotherapy for Glioblastoma: The Empire Strikes Back
(Fabio M. Iwamoto, M.D.)

TTFields: The Great Debate
(Pro: Nicholas Avgeropoulos, M.D.)
(Con: Jaishri Blakeley, M.D.)

Role of Immunotherapy in Gliomas
(Linda M. Liau, M.D.)

Panel Questions and Answers
(Moderator: Yazmin Odia, M.D.
(Panel: Fabio M. Iwamoto, M.D., Nicholas Avgeropoulos, M.D., Jaishri Blakeley, M.D., Linda M. Liau, M.D.)

Visit Posters and Exhibits
1:05 p.m.

Hits of 2019

[Moderator: Minesh Mehta, M.D.]

Craniopharyngiomas: Revolutionary Advances
(Priscilla Brastianos, M.D.)

Neurofibromatosis: Treatment Advances
(Jaishri Blakeley, M.D.)

Cognitive Preservation Strategies in Radiation Therapy
(Rakesh Jalali, M.D.)

Midline Gliomas: Changing the Landscape
(Yazmin Odia, M.D.)
3:15 p.m.
Adjourn and Closing Remarks
(Minesh Mehta, M.D.)
5:00 p.m.

Educational Objectives and Accreditation & Credits

Upon completion of this conference, participants should be better able to:

Educational Objectives

  • Examine the role of molecular histopathology in the diagnosis, characterization, and management of primary and metastatic brain tumors.
  • Recognize the strengths and limitations of advanced imaging in the diagnosis and post-treatment follow-up of patients with spine tumors.
  • Apply advances in systemic therapy, tumor neurosurgery, and radiation therapy to achieve contemporary management of primary brain tumors.
  • Examine recent breakthroughs in systemic therapy, neurology, and radiotherapeutics which influence management of patients with CNS malignancies.
  • Evaluate the management of brain and spinal metastasis in the modern era, focusing on the individual and collective roles of radiation therapy, targeted therapy, immunotherapy, and neurosurgery.

Accreditation and Credits

  • Baptist Health provides accredited continuing education (CME/CE) to doctors, nurses and allied health professionals.

  • Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

  • Baptist Health South Florida designates this live activity for a maximum of 7 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Automaticall Reports
    To CE Broker

  • Osteopathic Medicine, Podiatric Medicine, Psychology and Physician Assistants
    This activity has been approved for 7 credit hours by the Florida Boards of Medicine, Osteopathic Medicine, Podiatric Medicine, Psychology and the Florida Council of Physician Assistants. (CE Broker #20-731802).

  • Dietary
    This activity has been approved by the Commission on Dietetic Registration for 7 CPEUs.

  • Nursing
    This activity has been approved for 7 contact hours by Florida State Board of Nursing. (CE Broker #20-731802).

  • Pharmacy
    This activity has been approved for 7 contact hours by the Florida State Board of Pharmacy, (CE Broker #20-731802).

  • Respiratory Therapy
    This activity has been approved for a total of 7 contact hours for respiratory therapy personnel in the category of Personal Growth by the State of Florida, AHCA provider #RCE58. (CE Broker #20-731802).

  • Radiology Technologists
    This activity has been approved for continuing education credits by the Florida Bureau of Radiation Control, Provider #3201106. 7 Credits (CE Broker #20-731802).

  • This educational activity has been endorsed by the Congress of Neurological Surgeons as relevant to the practice of Neurological Surgery and meets the criteria for Category 1 Neurosurgical Credits as defined by the American Board of Neurological Surgery.

  • CNS seal logo

  • Important Notice Regarding Partial Credit and Attendance

  • Physicians: should claim only the credit commensurate with the extent of their participation in the symposium.

  • Physician Assistants, Dietitians, Nurses, Pharmacists, Respiratory Therapists, Radiology Technologists: Sign-in and completion of an evaluation form are required in order to receive a certificate. Accrediting organizations require that attendees remain in the symposium for the entire sessioncertificates for each session will only be issued to those that attend a session in its entirety.

  • ASET - The Neurodiagnostic Society
    7.5 ASET-CEUs are awarded for completion of this course.

  • The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Summit Registration

Registration Fees

Physicians $295*
Other Healthcare Professionals $95
Baptist Health Employees $55
Fellows/Residents $95**

Symposium fee includes Continental Breakfast, Breaks and lunch on Friday.

*Group discount available for physicians when three or more register together as a group by Friday, November 29.

Add-ons will not be accepted. Call 786-596-2398 for details.

**Registration must be accompanied by a letter from the Fellowship/Residency Director.​

Mail-In Registration

With check payment only to Baptist Health CME Department, 8900 North Kendall Drive, Miami, Florida 33176.

Online Registration

Pay via Master Card, Visa, American Express online
NOTE: Credit card payment will not be accepted over the phone.
  • Disclosure Policy

    Baptist Health has a process in place to ensure balance, independence, objectivity and scientific rigor in CME programming. Through this process Baptist Health identifies and, when applicable, resolves conflicts of interest of all individuals in a position to control or influence CME content, including faculty, conference directors, planners, content reviewers, CME Committee members and the CME Department staff. The CME Department is responsible for content review and, when necessary, makes modifications to resolve conflicts of interest so final presentations are fair and unbiased.

    These efforts are intended to affirm that the educational content is not controlled or influenced – directly or indirectly – by a commercial interest. As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

    Individuals participating in this CME activity are responsible for identifying references to off-label or unapproved product usage in their discussions and recommendations.

    Non-faculty Contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

    Copyright

    Baptist Health is not responsible for any image/illustration content prepared by faculty members for their presentations.

    Disclosures

    Disclosures for individuals in a position to control or influence content are provided below:

    Kevin Abrams, M.D., has disclosed that he serves as a consultant to Keystone Heart, and that he is a stock shareholder in Cleerly and Keystone Heart. Dr. Abrams has indicated that his presentation will not include discussion of off-label or unapproved usage.

    Nicholas G. Avgeropoulos, M.D., has disclosed that he is a member of the speaker’s bureau for Novocure. Dr. Avgeropoulos has also disclosed that his presentation will include discussion of off-label or unapproved usage.

    Mark H. Bilsky, M.D., has disclosed that he serves as a consultant to Globus, and is a member of the speaker’s bureau for Globus and Varian Medical Systems. Dr. Bilsky has indicated that his presentation(s) will not include discussion of off-label or unapproved usage.

    Jaishri Blakeley, M.D., has disclosed that she serves as a consultant to AstraZeneca Pharmaceuticals, Exelixis and Guidepoint Global, LLC. Dr. Blakeley has indicated that her presentation will include discussion of off-label or unapproved usage.

    Priscilla Brastianos, M.D., has disclosed that she receives grant/research support from Merck and Pfizer, and that she serves as a consultant to Angiochem, Genentech/Roche, Lilly and Tesaro, and is a member of the speaker’s bureau for Genentech/Roche and Merck. Dr. Brastianos has also disclosed that her presentations will include discussion of off-label or unapproved usage.

    Paul Brown, M.D., has disclosed that he receives personal fees from UpToDate (contributor) outside the submitted work. Dr. Brown has also disclosed that his presentation will include discussion of off-label or unapproved usage.

    Matthew Hall, M.D., has disclosed that he receives grant/research support from the Live Like Bella Pediatric Research Initiative through the Florida Department of Health, Grant 8LA04, and that he has received honoraria from Viewray, Inc. Dr. Hall has indicated that his panel/case discussion will not include discussion of off-label or unapproved usage.

    Fabio Iwamoto, M.D., has disclosed that he receives institutional research support from Novocure, Bristol-Myers Squibb, Celldex, Northwest Biotherapeutics, Stemline, Regeneron, Incyte, Immunocellular Therapeutics, Merck and Forma; also, Dr. Iwamoto serves as a consultant to Merck, Novocure, Regeneron, Abbvie, Alexion, Guidepoint and Tocagen, and is a stock shareholder in Prime Oncology. Dr. Iwamoto has also disclosed that his presentation will include discussion of off-label or unapproved usage.

    Rupesh Kotecha, M.D., has disclosed that he has received an honorarium from ACCURAY, Inc., Elekta and Elsevier, and that he is a member of the clinical advisory board for ACCURAY, Abbvie and Novocure. Dr. Kotecha has indicated that his presentation will not include discussion of off-label or unapproved usage.

    Linda Liau, M.D., has indicated that she has no relevant commercial relationships to disclose. Dr. Liau has disclosed that her presentation will include discussion of offlabel or unapproved usage.

    Minesh Mehta, M.D., has disclosed that he serves as a consultant to Celgene, Tocagen, Abbvie and Astra Zeneca, and that he is a member of the Board of Directors for Oncoceutics; Dr. Mehta has also disclosed that he is a member of the medical advisory boards for Colby, Stemina and Procertus. Dr. Mehta has indicated that his panel/case discussion will include discussion of off-label or unapproved usage.

    Yazmin Odia, M.D., has disclosed that she receives grant/research support from Bristol-Myers Squibb, Novocure and Oncoceutics, and that she serves as a consultant to Oncoceutics. Dr. Odia has indicated that her presentation will include discussion of off-label or unapproved usage.

    Brian Schiro, M.D., has disclosed that he is a member of the speaker’s bureau for Penumbra and Philips Medical. Dr. Schiro has indicated that his presentation will not include discussion of off-label or unapproved usage. 

    Sarah Weiss, M.D., has disclosed that she serves as a consultant to Array Biopharma and Magellan Rx. Dr. Weiss has also disclosed that her presentation will include discussion of off-label or unapproved usage.

    Nothing to Disclose

    The following faculty members indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentations or discussions:

    Rakesh Jalali, M.D.
    Vitaly Siomin, M.D.

  • All summit activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered summit attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in the summit areas. Badges provided at registration are required for entrance into all functions and will be strictly enforced.

  • In consideration of the Americans with Disabilities Act, please contact us to determine your special service requirements.

  • Changes may occur that are beyond our control. In the unforeseen event the symposium is canceled, Baptist Health will refund attendees the entire amount of their registration fees. If you are traveling from outside of the area, we strongly suggest purchasing travel insurance.

    Cancellations must be received by November 21, 2019.  to receive a refund of the registration fee, less a $25 administrative fee. Registration fees are not refundable after November 21, 2019.

Symposium Directors & Guest Faculty

  • Yazmin Odia, M.D., M.S.

    Yazmin Odia, M.D., M.S.

    Symposium Director

    Neuro-oncologist
    Miami Cancer Institute
    Miami, Florida

  • Rupesh Kotecha, M.D.

    Rupesh Kotecha, M.D.

    Symposium Director

    Radiation Oncologist
    Miami Cancer Institute
    Miami, Florida

  • Minesh P. Mehta, M.D.

    Minesh P. Mehta, M.D.

    Symposium Director

    Deputy Director and Chief of Radiation Oncology
    Miami Cancer Institute
    Miami, Florida

  • Vitaly Siomin, M.D.

    Vitaly Siomin, M.D.

    Symposium Director

    Neurosurgeon and Medical Director
    Brain Tumor Program at Baptist Health Neuroscience Center
    Miami, Florida

Location and Accommodations

Location and Accommodations

The Hilton Miami Dadeland
9100 N. Kendall Drive, Miami, FL 33176
786-975-1920

Reserve your room at the corporate rate plus applicable taxes at MiamiDadeland.Hilton.com or 786-975-1920. Rates are seasonal and based on availability.

Room Rates Course Date
$189 December*
*Based on 2019 rate schedule and is subject to change.

NOTE: Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session. (This does not apply to M.D.s and D.O.s.)

Photography

By attending our symposium, you consent to photography and videography of your image and likeness for use on Baptist Health websites, social media pages and press releases distributed for marketing purposes. Should you not agree to be photographed or recorded, you are responsible to notify us prior to this symposium.

Photography and recording of presenters and presentations are prohibited in the General Session, unless authorized by Baptist Health South Florida.

Disclaimer

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.